Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Goodman

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|June 1, 1997
Children's Yale-Brown Obsessive Compulsive Scale: reliability and validityL Scahill, M A Riddle, M McSwiggin-Hardin, et al.
Biological Psychiatry|July 15, 1995
Effects of tryptophan depletion on responses to yohimbine in healthy human subjectsA W Goddard, D S Charney, M Germine, et al.
Archives of General Psychiatry|November 1, 1989
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliabilityW K Goodman, L H Price, S A Rasmussen, et al.
Psychiatry Research|May 20, 1999
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorderA W Goddard, S W Woods, R Money, et al.
Biological Psychiatry|June 5, 1999
Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor thresholdW J Triggs, K J McCoy, R Greer, et al.
The American Journal of Psychiatry|March 1, 1997
B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?T K Murphy, W K Goodman, M W Fudge, et al.
The American Journal of Psychiatry|April 1, 1993
Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorderC J McDougle, W K Goodman, J F Leckman, et al.
Acta Psychiatrica Scandinavica|November 8, 2007
Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorderE A Storch, L J Merlo, M J Larson, et al.
Biological Psychiatry|December 1, 1994
Effects of tryptophan depletion in panic disorderA W Goddard, D E Sholomskas, K E Walton, et al.
Biological Psychiatry|August 1, 1995
m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbationW K Goodman, C J McDougle, L H Price, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Child and Adolescent Psychiatry|June 1, 1997
Children's Yale-Brown Obsessive Compulsive Scale: reliability and validityL Scahill, M A Riddle, M McSwiggin-Hardin, et al.
Biological Psychiatry|July 15, 1995
Effects of tryptophan depletion on responses to yohimbine in healthy human subjectsA W Goddard, D S Charney, M Germine, et al.
Archives of General Psychiatry|November 1, 1989
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliabilityW K Goodman, L H Price, S A Rasmussen, et al.
Psychiatry Research|May 20, 1999
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorderA W Goddard, S W Woods, R Money, et al.
Biological Psychiatry|June 5, 1999
Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor thresholdW J Triggs, K J McCoy, R Greer, et al.
The American Journal of Psychiatry|March 1, 1997
B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?T K Murphy, W K Goodman, M W Fudge, et al.
The American Journal of Psychiatry|April 1, 1993
Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorderC J McDougle, W K Goodman, J F Leckman, et al.
Acta Psychiatrica Scandinavica|November 8, 2007
Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorderE A Storch, L J Merlo, M J Larson, et al.
Biological Psychiatry|December 1, 1994
Effects of tryptophan depletion in panic disorderA W Goddard, D E Sholomskas, K E Walton, et al.
Biological Psychiatry|August 1, 1995
m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbationW K Goodman, C J McDougle, L H Price, et al.
Pageof 10